title: Recurrent hypoventilation and respiratory failure during gabapentin therapy.
authors.forename: S B
authors.initials: SB
authors.lastname: Batoon
authors.forename: A T
authors.initials: AT
authors.lastname: Vela
authors.forename: D
authors.initials: D
authors.lastname: Dave
authors.forename: Z
authors.initials: Z
authors.lastname: Wahid
authors.forename: R
authors.initials: R
authors.lastname: Conetta
authors.forename: C
authors.initials: C
authors.lastname: Iakovou
authors.forename: M
authors.initials: M
authors.lastname: Banzuela
mesh_terms: D000085:Acetates / Q000009:adverse effects*; D000368:Aged; D000588:Amines; D000700:Analgesics / Q000009:adverse effects*; D014151:Anti-Anxiety Agents / Q000009:adverse effects*; D000927:Anticonvulsants / Q000009:adverse effects*; D003509:Cyclohexanecarboxylic Acids; D000077206:Gabapentin; D006801:Humans; D007040:Hypoventilation / Q000139:chemically induced*; D008173:Lung Diseases, Obstructive / Q000188:drug therapy; D008297:Male; D010523:Peripheral Nervous System Diseases / Q000188:drug therapy; D012131:Respiratory Insufficiency / Q000139:chemically induced*; D005680:gamma-Aminobutyric Acid
chemical_list: D000085:Acetates; D000588:Amines; D000700:Analgesics; D014151:Anti-Anxiety Agents; D000927:Anticonvulsants; D003509:Cyclohexanecarboxylic Acids; D005680:gamma-Aminobutyric Acid; D000077206:Gabapentin